Guidelines for the indications to test for and to treat Helicobacter pylori infection: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 7: | Line 7: | ||
{| class="wikitable" | {| class="wikitable" | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:LightGreen" | | | colspan="1" style="text-align:center; background:LightGreen" |Strong recommendation | ||
|- | |- | ||
| bgcolor="LightGreen" |1.Since all patients with a positive test of active infection with H. pylori should be offered treatment, the critical issue is which patients should be tested for the | | bgcolor="LightGreen" |1.Since all patients with a positive test of active infection with H. pylori should be offered treatment, the critical issue is which patients should be tested for the | ||
| Line 21: | Line 21: | ||
should be offered eradication therapy. | should be offered eradication therapy. | ||
|- | |- | ||
| bgcolor="LightGreen" |Patients with typical symptoms of gastroesophageal reflux disease (GERD) who do not have a history of PUD need not be tested for H. pylori infection. | | bgcolor="LightGreen" |4.Patients with typical symptoms of gastroesophageal reflux disease (GERD) who do not have a history of PUD need not be tested for H. pylori infection. | ||
However, for those who are tested and found to be infected, treatment should be offered, acknowledging that effects on GERD symptoms are unpredictable | However, for those who are tested and found to be infected, treatment should be offered, acknowledging that effects on GERD symptoms are unpredictable | ||
|- | |- | ||
|} | |} | ||
Revision as of 23:58, 30 November 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2], Sargun Singh Walia M.B.B.S.[3]
2017 ACG guidelines for the indications to test for and to treat Helicobacter pylori infection
| Strong recommendation |
| 1.Since all patients with a positive test of active infection with H. pylori should be offered treatment, the critical issue is which patients should be tested for the
infection . |
| 2.All patients with active peptic ulcer disease (PUD), a past history of PUD (unless previous cure of H. pylori infection has been documented), low-grade
gastric mucosa-associated lymphoid tissue (MALT) lymphoma or a history of endoscopic resection of early gastric cancer (EGC) should be tested for H. pylori infection. Those who test positive should be offered treatment for the infection. |
| 3. When upper endoscopy is undertaken in patients with dyspepsia, gastric biopsies should be taken to evaluate for H. pylori infection. Infected patients
should be offered eradication therapy. |
| 4.Patients with typical symptoms of gastroesophageal reflux disease (GERD) who do not have a history of PUD need not be tested for H. pylori infection.
However, for those who are tested and found to be infected, treatment should be offered, acknowledging that effects on GERD symptoms are unpredictable |